S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Better Than Oil Stocks (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Better Than Oil Stocks (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Better Than Oil Stocks (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Better Than Oil Stocks (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
NASDAQ:NOTV

Inotiv (NOTV) Stock Price, News & Analysis

$5.58
-0.37 (-6.22%)
(As of 02/23/2024 ET)
Today's Range
$5.11
$5.91
50-Day Range
$3.27
$6.37
52-Week Range
$1.61
$8.07
Volume
678,650 shs
Average Volume
341,320 shs
Market Capitalization
$143.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.17

Inotiv MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
171.8% Upside
$15.17 Price Target
Short Interest
Bearish
4.55% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.70mentions of Inotiv in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$163,804 Bought Last Quarter
Proj. Earnings Growth
23.08%
From $1.04 to $1.28 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.62 out of 5 stars

Medical Sector

270th out of 943 stocks

Commercial Physical Research Industry

5th out of 13 stocks


NOTV stock logo

About Inotiv Stock (NASDAQ:NOTV)

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services, including computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes general and genetic toxicology, regulated bioanalysis, carcinogenicity studies, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services, as well as model and research services. The company operates in the United States, the Netherlands, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

NOTV Stock Price History

NOTV Stock News Headlines

Inotiv Stock (NASDAQ:NOTV) Insider Trades
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Are Investors Undervaluing Inotiv (NOTV) Right Now?
The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
Inotiv First Quarter 2024 Earnings: Beats Expectations
Inotiv: The Business Is Recovering, The Stock Will Follow
John Beattie Bought 85% More Shares In Inotiv
See More Headlines
Receive NOTV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inotiv and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/11/2023
Today
2/24/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:NOTV
Employees
2,055
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.17
High Stock Price Target
$25.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+171.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-105,140,000.00
Pretax Margin
-6.95%

Debt

Sales & Book Value

Annual Sales
$572.42 million
Cash Flow
$0.40 per share
Book Value
$9.85 per share

Miscellaneous

Free Float
24,295,000
Market Cap
$143.91 million
Optionable
Optionable
Beta
2.87
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Robert W. Leasure Jr. (Age 64)
    President, CEO & Director
    Comp: $2M
  • Dr. John E. Sagartz D.V.M. (Age 58)
    DiplomateACVP, Ph.D., Chief Strategy Officer & Director
    Comp: $438.61k
  • Dr. Peter T. Kissinger (Age 79)
    Founder, Chairman Emeritus & Scientific Advisor
    Comp: $330.12k
  • Mr. Brennan Freeman (Age 37)
    VP of Finance, Principal Accounting Officer & Corporate Controller
  • Ms. Andrea Castetter
    Senior VP, General Counsel & Corporate Secretary
  • Dr. Adrian Hardy Ph.D. (Age 53)
    Executive VP of Global Marketing & Corporate Development
    Comp: $2.74M
  • Mr. Jeffrey Arthur Krupp (Age 53)
    Chief Human Resources Officer
  • Mr. John Gregory Beattie DSA (Age 57)
    Chief Operating Officer of DSA
  • Mr. Michael Garrett M.S. (Age 56)
    Chief Commercial Officer
  • Mr. Glenn Washer B.Sc. (Age 57)
    DABT, Group President of Safety Assessment














NOTV Stock Analysis - Frequently Asked Questions

Should I buy or sell Inotiv stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inotiv in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NOTV shares.
View NOTV analyst ratings
or view top-rated stocks.

What is Inotiv's stock price target for 2024?

3 Wall Street analysts have issued 1-year price objectives for Inotiv's stock. Their NOTV share price targets range from $9.00 to $25.00. On average, they expect the company's share price to reach $15.17 in the next year. This suggests a possible upside of 171.8% from the stock's current price.
View analysts price targets for NOTV
or view top-rated stocks among Wall Street analysts.

How have NOTV shares performed in 2024?

Inotiv's stock was trading at $3.67 at the beginning of the year. Since then, NOTV shares have increased by 52.0% and is now trading at $5.58.
View the best growth stocks for 2024 here
.

Are investors shorting Inotiv?

Inotiv saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 1,040,000 shares, an increase of 6.7% from the January 15th total of 974,800 shares. Based on an average trading volume of 259,700 shares, the days-to-cover ratio is presently 4.0 days. Approximately 4.6% of the company's shares are short sold.
View Inotiv's Short Interest
.

When is Inotiv's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our NOTV earnings forecast
.

How were Inotiv's earnings last quarter?

Inotiv, Inc. (NASDAQ:NOTV) released its earnings results on Monday, December, 11th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of $0.11 by $0.40. The business had revenue of $140.74 million for the quarter, compared to analysts' expectations of $140.21 million. Inotiv had a negative net margin of 5.67% and a negative trailing twelve-month return on equity of 10.99%.

What guidance has Inotiv issued on next quarter's earnings?

Inotiv updated its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $580.0 million-$590.0 million, compared to the consensus revenue estimate of $578.1 million.

Who are Inotiv's major shareholders?

Inotiv's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (4.01%), Balyasny Asset Management L.P. (3.78%), KPP Advisory Services LLC (0.64%), Wynnefield Capital Inc. (0.58%), King Luther Capital Management Corp (0.38%) and Northern Trust Corp (0.13%). Insiders that own company stock include Gregory Cole Davis, James Harkness, John E Sagartz, John E Sagartz, John Gregory Beattie, Michael Garrett, Philip A Downing, R Matthew Neff, Robert Jr Leasure and William D Pitchford.
View institutional ownership trends
.

How do I buy shares of Inotiv?

Shares of NOTV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NOTV) was last updated on 2/24/2024 by MarketBeat.com Staff